We believe that Trevali is extremely cheap, trading at 0.4x NAV of approximately $2.00 per share, and 0.8x tangible book value. As Trevali continues to demonstrate the production and cash flow capability of its mines, we believe there is significant potential for an upward valuation re-rating for the stock. Moreover, given that zinc could move into a supply deficit within the next two years and the lack of common stocks with significant leverage to zinc, we believe that Trevali could eventually become a take-over candidate.
Operationally, we were pleased to see that the Santander mine, located in Peru, operated at full capacity of 2,000 tpd in the month of October. Given that Santander is a relatively low cost mine, we believe Trevali has significant operating leverage given the current zinc price of approximately $0.85/lb and potential to increase production. The company is also advancing its New Brunswick assets, including the Caribou mine and mill, Halfmile mine, and Stratmat deposit, with commercial production targeted for 2014. The company has life-of-mine off-take agreements with Glencore Xstrata plc, the largest global zinc miner, for all concentrates produced at the Santander and Caribou mines. Glencore Xstrata is also a significant shareholder of Trevali and has a representative on the company’s Board of Directors.
We continue to believe that Trevali maintains a strong financial position. On November 28th, the company completed a $46 million equity financing, consisting of 55.43 million common shares priced at $0.83 per share. Proceeds will be used to pay for expenses relating to the restart of the Caribou mine and mill and for general working capital purposes. Post the financing, we believe that Trevali is well capitalized to pursue its development and exploration objectives.